Skip to main content
. Author manuscript; available in PMC: 2010 Aug 30.
Published in final edited form as: J Expo Sci Environ Epidemiol. 2009 Feb 18;20(1):90–100. doi: 10.1038/jes.2009.4

Table 2.

Distribution of creatinine-adjusted (μg/g creatinine) (in bold) and unadjusted (μg/L) phthalate metabolite concentrations in urine samples from 45 women*

%> LOD Geometric Mean Geometric Std Dev Percentiles
25th 50th 75th 95th Min Max
MEP 100 59.6 2.7 29.7 62.3 103.4 355.7 13.3 3866.6
63.9 3.0 32.9 63.0 116.9 313.5 6.9 5424.9
MnBP 100 25.2 1.9 17.5 25.4 40.0 83.9 6.9 127.1
27.1 2.6 14.1 26.1 55.1 122.7 3.6 287.7
MiBP 100 7.5 1.7 5.5 7.9 11.3 18.1 2.2 20.1
8.0 2.2 5.5 8.9 13.5 29.5 1.4 41.8
MBzP 100 20.9 2.2 15.6 23.0 38.1 65.4 2.8 90.1
22.4 2.6 12.8 30.1 48.9 105.2 3.6 191.7
MCPP 93 1.6 2.6 1.3 1.8 3.1 4.9 0.1 19.7
1.8 3.0 1.2 2.2 3.9 9.1 0.1 14.7
MEHP 81 3.4 2.4 2.3 3.5 9.1 21.3 0.5 36.0
3.6 2.6 2.6 4.5 7.7 22.2 0.6 30.8
MECPP 100 29.5 2.2 17.5 32.6 52.7 164.4 6.3 243.4
31.7 2.5 16.9 36.0 82.5 192.7 6.2 226.5
MEHHP 100 19.5 2.2 10.7 20.3 36.8 138.4 3.9 251.3
20.9 2.4 11.3 21.4 51.6 156.6 4.6 268.2
MEOHP 100 13.0 2.1 7.6 13.4 25.3 83.1 3.1 103.9
13.9 2.4 8.6 13.5 36.5 84.1 2.6 164.3
ΣDEHP - 67.3 2.1 41.0 68.9 128.7 462.1 14.5 540.9
72.1 2.4 41.2 71.6 180.6 452.9 14.5 686.5
*

Values based on mean concentrations for 45 women providing one to three urine samples

HHS Vulnerability Disclosure